Autoantibodies to human melanocyte‐specific protein Pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA)

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Clinical and Experimental Immunology

• Publication date

  1998-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2249.1998.00746.xPMID 9844040PMCID PMC1905130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoantibodies to tyrosinase‐related protein‐1 detected in the sera of vitiligo patients using a quantitative radiobinding assay

  1998cited by this paper
• Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineagespecific antigen gp100

  1997cited by this paper
• Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross‐reactive autoantibodies to tyrosinase and tyrosinase‐related protein‐2 (TRP‐2)

  1997cited by this paper
• Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay.

  1997cited by this paper
• Genomic organization and sequence of D12S53E (Pmel 17), the human homologue of the mouse silver (si) locus.

  1996cited by this paper
• Tyrosinase as an autoantigen in patients with vitiligo

  1996cited by this paper
• Detection of candidal antigens in autoimmune polyglandular syndrome type I

  1996cited by this paper
• Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo.

  1995cited by this paper
• High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase.

  1995cited by this paper
• Characterization of vitiligo antigens.

  1995cited by this paper
• Melanocyte lineage-specific antigen gp100 is recognized by melanoma- derived tumor-infiltrating lymphocytes

  1994cited by this paper
• Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes.

  1994cited by this paper
• Molecular characterization of the melanocyte lineage-specific antigen gp100.

  1994cited by this paper
• Cloning and Expression of the Gene for the Melanoma-Associated ME20 Antigen

  1994cited by this paper
• Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2.

  1994cited by this paper
• The Pmel 17/silver locus protein. Characterization and investigation of its melanogenic function.

  1994cited by this paper
• Identification of a melanosomal matrix protein encoded by the murine si (silver) locus using "organelle scanning".

  1994cited by this paper
• Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

  1994cited by this paper
• The role of tyrosinase in autoimmune vitiligo.

  1994cited by this paper
• Pigmentation genes: the tyrosinase gene family and the pmel 17 gene family.

  1993cited by this paper
• Vitiligo autoantibodies are effective against melanoma

  1993cited by this paper
• Identification of pigment cell antigens defined by vitiligo antibodies.

  1992cited by this paper
• A second tyrosinase‐related protein, TRP‐2, is a melanogenic enzyme termed DOPAchrome tautomerase.

  1992cited by this paper
• Complete sequence and expression of a cDNA encoding a chicken 115-kDa melanosomal matrix protein.

  1991cited by this paper
• A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12.

  1991cited by this paper
• Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo.

  1991cited by this paper
• Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity.

  1988cited by this paper
• A melanocyte-specific complementary DNA clone whose expression is inducible by melanotropin and isobutylmethyl xanthine.

  1987cited by this paper
• Correlation between vitiligo antibodies and extent of depigmentation in vitiligo.

  1986cited by this paper
• Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation.

  1983cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• The immunology of vitiligo.

  2026cites this paper
• Genomic and ancestral variations linked to the development of post-acute sequelae of SARS-CoV-2 infection in Indian populations

  2026cites this paper
• The Immunogenetics of Vitiligo: An Approach Toward Revealing the Secret of Depigmentation.

  2022cites this paper
• Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors

  2021cites this paper
• Comparison of tyrosinase antibody, tyrosinase-related protein-1 and -2 antibodies, melanin-concentrating hormone receptor antibody levels with autologous serum skin test and autologous plasma skin test results in patients with vitiligo

  2020cites this paper
• A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer.

  2020cites this paper
• Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders

  2020cites this paper
• The attentive focus on T cell‐mediated autoimmune pathogenesis of psoriasis, lichen planus and vitiligo

  2020cites this paper
• Cytokine profile (IL‐2, IL‐6, IL‐17, IL‐22, and TNF‐α) in vitiligo—New insight into pathogenesis of disease

  2019cites this paper
• Premature cell senescence in human skin: dual face in chronic acquired pigmentary disorders.

  2019cites this paper
• Identification of the Risk HLA-A Alleles and Autoantigen in Han Chinese Vitiligo Patients and the Association of CD8+T Cell Reactivity with Disease Characteristics

  2018cites this paper
• Vitiligo and Autoimmune Thyroid Disorders

  2017cites this paper
• Association of protein tyrosine phosphatase, non-receptor type 22 +1858C→T polymorphism and susceptibility to vitiligo: Systematic review and meta-analysis

  2017cites this paper
• Relationship between vitiligo and Hashimoto's thyroiditis

  2017cites this paper
• Hashimoto’s thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases

  2016cites this paper
• Vitiligo – A Complex Autoimmune Skin Depigmenting Disease

  2015cites this paper
• Oxidative Stress and Immune System in Vitiligo and Thyroid Diseases

  2015cites this paper
• Vitiligo, Melanoma Associated Hypopigmentation and Melanoma Incidence and Prognosis: Is There An Association?

  2015cites this paper
• Immunological Basis of Melanoma-Associated Vitiligo-Like Depigmentation

  2014cites this paper
• Immunological basis of melanoma-associated vitiligo-like depigmentation.

  2014cites this paper
• Bases inmunológicas de la hipopigmentación vitiligoide asociada a melanoma

  2014cites this paper
• A Monoclonal Antibody Against PMEL

  2014cites this paper
• Vitiligo: a review of the pathogenesis

  2014cites this paper
• Could ER Stress Be A Major Link Between Oxidative Stress And Autoimmunity In Vitiligo

  2014cites this paper
• Melanocyte antigen‐specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo

  2013cites this paper
• Vitiligo patients from India (Mumbai) show differences in clinical, demographic and autoantibody profiles compared to patients in western countries

  2013cites this paper
• Vitiligo: interplay between oxidative stress and immune system

  2013cites this paper
• Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients

  2012cites this paper
• Potential Role of Neurogenic Inflammatory Factors in the Pathogenesis of Vitiligo

  2012cites this paper
• An Investigation of Autoantibodies against Tyrosine Hydroxylase in Patients with Vitiligo

  2012cites this paper
• Vitiligo autoantigen VIT75 is identified as lamin A in vitiligo by serological proteome analysis based on mass spectrometry.

  2011cites this paper
• Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata

  2011cites this paper
• Nonsegmental Vitiligo and Autoimmune Mechanism

  2011influential citation
• Autoantibodies against tyrosine hydroxylase in patients with non‐segmental (generalised) vitiligo

  2011cites this paper
• Immunodetection of the MCHR1 antibody in vitiligo patient sera.

  2011cites this paper
• Autoimmunity in Vitiligo

  2011cites this paper
• The Double Strike Hypothesis of the vitiligo pathomechanism: new approaches to vitiligo and melanoma.

  2010cites this paper
• Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library.

  2010cites this paper
• Update on childhood vitiligo

  2010cites this paper
• Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor

  2010cites this paper
• Immune/Inflammatory Aspects

  2010cites this paper
• MART-1 transcript is absent in PBMCs from Vitiligo patients

  2009cites this paper
• Melanocyte survival and response to treatment in Vitiligo Patients

  2009cites this paper
• Absence of Tyrosinase‐Related Protein‐2/Dopachrome Tautomerase Transcripts in PBMCs from Vitiligo Patients

  2009cites this paper
• Prediction and prevention of autoimmune skin disorders

  2008cites this paper
• Vitiligo following a combined liver-kidney transplant.

  2008cites this paper
• Aspectos imunopatológicos do vitiligo

  2008cites this paper
• Autoimmunity as an aetiological factor in vitiligo

  2007cites this paper
• Harnessing Autoimmunity (Vitiligo) to Treat Melanoma

  2007cites this paper
• AUTOANTIBODIES TO MUCOCUTANEOUS ANTIGENS

  2007cites this paper
• Melanokortiini süsteemiga seotud geenide ekspressiooni uurimine vitiliigopatsientide nahas

  2007cites this paper
• RR 2 Vitiligo : : A review

  2007cites this paper
• Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.

  2007cites this paper
• Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.

  2006cites this paper
• Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes.

  2006cites this paper
• Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients

  2006cites this paper
• The role of T cells in cutaneous autoimmune disease

  2005cites this paper
• Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.

  2005cites this paper
• Cell-mediated immunity in poultry.

  2004cites this paper
• Autoantibodies as diagnostic and predictive markers of vitiligo.

  2004cites this paper
• Autoantibodies as Diagnostic and Predictive Markers of Vitiligo

  2004cites this paper
• Participation of the intestinal epithelium and mast cells in local mucosal immune responses in commercial poultry.

  2004cites this paper
• Evidence for an autoimmune pathogenesis of vitiligo.

  2003cites this paper
• Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor.

  2003cites this paper
• Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients.

  2003cites this paper
• Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1

  2002cites this paper
• The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo.

  2002cites this paper
• The Transcription Factors SOX9 and SOX10 Are Vitiligo Autoantigens in Autoimmune Polyendocrine Syndrome Type I*

  2001cites this paper
• Autoimmune Melanocyte Destruction in Vitiligo

  2001cites this paper
• MINIREVIEW Autoimmune Melanocyte Destruction in Vitiligo

  2001cites this paper
• Immunological pathomechanisms in vitiligo

  2001cites this paper
• Identification of antigenic domains on the human sodium‐iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease

  2001cites this paper
• Molecular mapping of epitopes on melanocyte‐specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo

  2001cites this paper
• Autoimmune Aspects of Vitiligo

  2001cites this paper
• Skin disorders and thyroid diseases

  2001cites this paper
• Detection of antigen‐specific cytotoxic T lymphocytes: significance for investigative dermatology

  2000cites this paper
• Recognition of melanoma cell antigens with antibodies present in sera from patients with vitiligo

  2000cites this paper
• Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.

  2000influential citation
• T cell immune responses against melanoma and melanocytes in cancer and autoimmunity.

  2000cites this paper